Hims & Hers Health Inc (NYSE: HIMS) kicked off on Monday, up 3.97% from the previous trading day, before settling in for the closing price of $27.23. Over the past 52 weeks, HIMS has traded in a range of $11.20-$72.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Consumer Defensive sector saw sales topped by 62.28%. While this was happening, its average annual earnings per share was recorded 14.37%. With a float of $181.95 million, this company’s outstanding shares have now reached $212.46 million.
The extent of productivity of a business whose workforce counts for 1637 workers is very important to gauge. In terms of profitability, gross margin is 76.65%, operating margin of 4.24%, and the pretax margin is 4.86%.
Hims & Hers Health Inc (HIMS) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Household & Personal Products Industry. The insider ownership of Hims & Hers Health Inc is 18.10%, while institutional ownership is 73.83%. The most recent insider transaction that took place on Apr 14 ’25, was worth 92,938. Before that another transaction happened on Apr 09 ’25, when Company’s Chief Operating Officer sold 33,337 for $27.32, making the entire transaction worth $910,687. This insider now owns 805,083 shares in total.
Hims & Hers Health Inc (HIMS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 32.17% during the next five years compared to 17.22% growth over the previous five years of trading.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
Take a look at Hims & Hers Health Inc’s (HIMS) current performance indicators. Last quarter, stock had a quick ratio of 1.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.26. Likewise, its price to free cash flow for the trailing twelve months is 31.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.53, a number that is poised to hit 0.12 in the next quarter and is forecasted to reach 0.88 in one year’s time.
Technical Analysis of Hims & Hers Health Inc (HIMS)
The latest stats from [Hims & Hers Health Inc, HIMS] show that its last 5-days average volume of 22.27 million was inferior to 22.88 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 40.77%. Additionally, its Average True Range was 3.79.
During the past 100 days, Hims & Hers Health Inc’s (HIMS) raw stochastic average was set at 16.80%, which indicates a significant decrease from 31.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 111.68% in the past 14 days, which was lower than the 123.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $38.62, while its 200-day Moving Average is $26.41. Now, the first resistance to watch is $29.14. This is followed by the second major resistance level at $29.97. The third major resistance level sits at $30.94. If the price goes on to break the first support level at $27.34, it is likely to go to the next support level at $26.37. The third support level lies at $25.54 if the price breaches the second support level.
Hims & Hers Health Inc (NYSE: HIMS) Key Stats
The company with the Market Capitalisation of 6.29 billion has total of 222,166K Shares Outstanding. Its annual sales at the moment are 1,477 M in contrast with the sum of 126,040 K annual income. Company’s last quarter sales were recorded 481,140 K and last quarter income was 26,030 K.
